image
PDS Biotechnology Corporation PDSB
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 2.01
-10.7 %
$ 74 M
Market Cap
-1.63
P/E
INCOME STATEMENT
0 REVENUE
0.00%
Growth Rates
1Year 0.00%
3Years 0.00%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-43 M OPERATING INCOME
-3.29%
Growth Rates
1Year -3.29%
3Years -42.42%
5Years 0.02%
7Years -1.23%
10Years -20.83%
-42.9 M NET INCOME
-5.11%
Growth Rates
1Year -5.11%
3Years -42.48%
5Years -1.00%
7Years -1.45%
10Years -20.09%
EFFICIENCY
Earnings Waterfall PDS Biotechnology Corporation
image
Revenue 0
Cost Of Revenue 57.3 K
Gross Profit -57.3 K
Operating Expenses 43 M
Operating Income -43 M
Other Expenses -103 K
Net Income -42.9 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
REVENUE
Revenue 0 0 0 0 0 0 0 0 0 0 0
GROSS PROFIT
Cost Of Revenue 57.3 K 49.1 K 0.2 0.2 98.4 K 69.1 K 0.2 0.1 53.1 K 0 0
Gross Profit 57.3 K 49.1 K (0.2) (0.2) 98.4 K 69.1 K (0.2) (0.1) 53.1 K 0 0
OPERATING INCOME
Operating Expenses 43.0 41.7 21.4 14.9 17.1 30.4 52.0 39.5 26.5 13.2 6.5
Selling, General and Administrative Expenses 15.3 12.2 10.2 7.0 11.0 14.3 17.7 14.7 8.7 4.7 2.0
Research and Development Expenses 27.8 29.4 11.3 7.9 6.1 16.1 34.3 24.8 17.8 8.5 4.5
Operating Income (43.0) (41.7) (21.4) (14.9) (21.0) (43.1) (52.0) (39.5) (26.5) (13.2) (6.5)
PRE-TAX INCOME
Interest Income Expense 4.2 1.3 0 0 33.6 K 1.4 2.2 1.2 0.8 0.2 3.35 K
Total Other Income (1.3) (0.4) 4.35 K 55 K 13.7 (0.2) (50.0) (36.4) (2.7) 0.4 (0.9)
Pre-Tax Income (44.3) (42.1) (21.4) (14.8) (7.4) (43.6) (53.4) (40.7) (29.2) (12.8) (7.3)
NET INCOME
Tax Provision (1.4) (1.2) (4.5) (0.1) (0.4) (2.8) (2.6) (1.8) (1.1) (0.6) (0.5)
Net Income (42.9) (40.9) (16.9) (14.8) (7.0) (40.9) (50.9) (38.8) (28.1) (12.2) (6.9)
EPS 1.39 1.43 0.66 0.89 1.44 26.2 33.5 26.9 69.4 16.1 9.11